Xilio Therapeutics, Inc 10-K for FY2025
Xilio Therapeutics, Inc. (XLO)
10-K
2026-03-23
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 10-K
Xilio Therapeutics, Inc filed this 10-K on March 23, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $43.77M
- up 589.9% from $6.34M a year earlier
- Net loss
- $35.04M
- compared with a net loss of $58.24M a year earlier
- Diluted EPS
- -$4.19
- compared with -$15.24 a year earlier